Cochlear implantation after canal wall down mastoidectomy - Outcomes after partial mastoid obliteration.


Journal

Auris, nasus, larynx
ISSN: 1879-1476
Titre abrégé: Auris Nasus Larynx
Pays: Netherlands
ID NLM: 7708170

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 02 08 2018
revised: 09 10 2018
accepted: 29 10 2018
pubmed: 18 11 2018
medline: 3 1 2020
entrez: 17 11 2018
Statut: ppublish

Résumé

To describe and evaluate the partial mastoid obliteration of the so-called radical mastoid cavity after canal-wall down mastoidectomy (CWD) for cochlear implantation (CI) compared to overclosure of the external ear canal as two stage procedures. Out of 1020 patients undergoing cochlear implantation between January 1st, 2003 and June 15th, 2016 at the Department of Otolaryngology, Head & Neck Surgery, University Hospital Cologne, eight patients underwent obliteration of the radical cavity prior to cochlear implantation. In four additional patients, the external ear canal was overclosed prior to cochlear implantation. Patients undergoing partial mastoid obliteration (five ♀, 4 left ears) and overclosure of the external ear canal (one ♀, 3 left ears) averaged 56years and 61years, respectively. The radical cavities had been present for 21.8years on average before partial obliteration and for 19.5years before overclosure. Cochlear implantation following mastoid obliteration was performed after a mean period of 5.1months and 3.8months after overclosure. After partial mastoid obliteration, complete insertion of all electrodes was achieved and the clinical courses were uneventful for all patients. Likewise, no patient revealed any complications after overclosure of the external ear canal. Partial mastoid obliteration with bone paté and cartilage after canal wall down mastoidectomy can be advocated as a feasible alternative technique that allows for a safe subsequent cochlear implantation.

Identifiants

pubmed: 30442436
pii: S0385-8146(18)30675-8
doi: 10.1016/j.anl.2018.10.016
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

487-492

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Matthias Balk (M)

Department of Otolaryngology, Head & Neck Surgery, University Hospital Erlangen, Germany; Department of Otolaryngology, Head & Neck Surgery, University Hospital Cologne, Germany. Electronic address: matthias.balk@uk-erlangen.de.

David Schwarz (D)

Department of Otolaryngology, Head & Neck Surgery, University Hospital Cologne, Germany.

Philipp Wolber (P)

Department of Otolaryngology, Head & Neck Surgery, University Hospital Cologne, Germany.

Andreas Anagiotos (A)

Department of Otolaryngology, Head & Neck Surgery, University Hospital Cologne, Germany; ENT Department, Nicosia General Hospital, Cyprus.

Antoniu-Oreste Gostian (AO)

Department of Otolaryngology, Head & Neck Surgery, University Hospital Erlangen, Germany; Department of Otolaryngology, Head & Neck Surgery, University Hospital Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH